目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key objectives of secondary research
2.1.1.2 Key sources of secondary data
2.1.1.3 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key primary sources
2.1.2.2 Key objectives of primary research
2.1.2.3 Key data from primary sources
2.1.2.4 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
2.2.2 TOP-DOWN APPROACH
2.2.3 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS
2.2.4 DEMAND-SIDE MODELLING
2.3 DATA TRIANGULATION
2.4 MARKET RANKING ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 MINIMALLY INVASIVE SURGERY MARKET OVERVIEW
4.2 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER AND COUNTRY
4.3 MINIMALLY INVASIVE SURGERY MARKET: GEOGRAPHIC SNAPSHOT
4.4 MINIMALLY INVASIVE SURGERY MARKET: REGIONAL MIX
4.5 MINIMALLY INVASIVE SURGERY MARKET: EMERGING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising geriatric population and increasing number of surgeries
5.2.1.2 Growing adoption of minimally invasive surgeries over traditional open surgical procedures
5.2.1.3 Advantages of robot-assisted surgery and training in rehabilitation therapy
5.2.2 RESTRAINTS
5.2.2.1 High cost of robotic systems
5.2.3 OPPORTUNITIES
5.2.3.1 High growth opportunities in emerging markets
5.2.3.2 Increasing adoption of advanced robotics in ambulatory surgery centers
5.2.4 CHALLENGES
5.2.4.1 Changing regulatory landscape in medical device industry
5.3 TECHNOLOGY ANALYSIS
5.3.1 KEY TECHNOLOGIES
5.3.1.1 Laparoscopy
5.3.1.2 Electrosurgery
5.3.2 COMPLEMENTARY TECHNOLOGIES
5.3.2.1 Robotic surgery
5.3.2.2 Medical and surgical imaging
5.3.3 ADJACENT TECHNOLOGIES
5.3.3.1 Artificial intelligence and machine learning
5.4 INDUSTRY TRENDS
5.4.1 INTEGRATION OF ARTIFICAL INTELLIGENCE AND MACHINE LEARNING
5.4.2 TECHNOLOGICAL ADVANCEMENTS IN IMAGING
5.5 VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.7 SUPPLY CHAIN ANALYSIS
5.8 TRADE ANALYSIS
5.8.1 IMPORT DATA FOR HS CODE 9018, 2019-2024
5.8.2 EXPORT SCENARIO FOR HS CODE 9018, 2019-2024
5.9 PORTER'S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF BUYERS
5.9.4 BARGAINING POWER OF SUPPLIERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 KEY STAKEHOLDERS & BUYING CRITERIA
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.10.2 KEY BUYING CRITERIA
5.11 REGULATORY ANALYSIS
5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2 REGULATORY FRAMEWORK
5.11.2.1 North America
5.11.2.1.1 US
5.11.2.1.2 Canada
5.11.2.2 Europe
5.11.2.3 Asia Pacific
5.11.2.3.1 Japan
5.11.2.3.2 China
5.11.2.3.3 India
5.11.2.4 Latin America
5.11.2.5 Middle East & Africa
5.12 PATENT ANALYSIS
5.12.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.13 PRICING ANALYSIS
5.13.1 AVERAGE SELLING PRICE TREND OF MINIMALLY INVASIVE SURGICAL PRODUCTS, BY KEY PLAYER
5.13.2 AVERAGE SELLING PRICE TREND OF MINIMALLY INVASIVE SURGICAL PRODUCTS, BY REGION, 2022-2024
5.14 KEY CONFERENCES & EVENTS, 2025-2026
5.15 ADJACENT MARKET ANALYSIS
5.15.1 ENDOSCOPY EQUIPMENT MARKET
5.16 UNMET NEEDS/END-USER EXPECTATIONS
5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
5.18 INVESTMENT & FUNDING SCENARIO
5.19 IMPACT OF AI/GEN AI ON MINIMALLY INVASIVE SURGERY MARKET
5.20 IMPACT OF 2025 US TARIFF ON MINIMALLY INVASIVE SURRGERY MARKET
5.20.1 INTRODUCTION
5.20.2 KEY TARIFF RATES
5.20.3 PRICE IMPACT ANALYSIS
5.20.4 KEY IMPACT ON COUNTRY/REGION
5.20.4.1 North America
5.20.4.1.1 US
5.20.4.2 Europe
5.20.4.3 Asia Pacific
5.20.5 IMPACT ON END-USE INDUSTRIES

6 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 SURGICAL DEVICES
6.2.1 HANDHELD INSTRUMENTS
6.2.1.1 Tubular retractors
6.2.1.1.1 Minimized tissue trauma and better outcomes to support adoption
6.2.1.2 Dilators
6.2.1.2.1 Increased focus on safety and efficient surgical site access to boost segment growth
6.2.1.3 Suturing instruments
6.2.1.3.1 Rising demand and procedural volume for minimally invasive surgeries to drive market
6.2.1.4 Probes
6.2.1.4.1 Advancements in instrumentation to fuel adoption in diagnostic purposes
6.2.1.5 Laser fiber devices
6.2.1.5.1 Laser fiber devices to focus on precise and controlled procedures with minimal tissue trauma
6.2.2 LAPAROSCOPY DEVICES
6.2.2.1 Laparoscopes
6.2.2.1.1 Lower surgical infection risk to drive demand
6.2.2.2 Trocars & cannulas
6.2.2.2.1 Need to ensure accurate placement of medications during surgeries to support segment growth
6.2.2.3 Graspers & dissectors
6.2.2.3.1 Increased safety and better precision to fuel market growth
6.2.3 INFLATION SYSTEMS
6.2.3.1 Balloon catheters
6.2.3.1.1 Increasing prevalence of cardiovascular diseases to boost market growth
6.2.3.2 Balloon inflation systems
6.2.3.2.1 Growing adoption of minimally invasive coronary and peripheral procedures to accelerate market growth
6.2.4 GUIDING DEVICES
6.2.4.1 Guiding catheters
6.2.4.1.1 Rising demand for precise navigation and device placement in complex minimally invasive surgeries to drive demand
6.2.4.2 Guidewires
6.2.4.2.1 Rising PCTA and PTA procedural volumes to ensure demand growth
6.3 IMAGING & VISUALIZATION SYSTEMS
6.3.1 ULTRASOUND SYSTEMS
6.3.1.1 Rising chronic disease burden to drive demand for reliable, non-invasive ultrasound imaging
6.3.1.2 CT scanners
6.3.1.2.1 Rising demand for high-resolution imaging in complex minimally invasive surgeries to support market growth
6.3.2 MRI SYSTEMS
6.3.2.1 Rising cancer prevalence to increase reliance on MRI for early detection and image-guided surgeries
6.3.3 X-RAY SYSTEMS
6.3.3.1 Rapid, low-cost digital imaging and high patient throughput to favor market growth
6.3.4 OTHER IMAGING & VISUALIZATION SYSTEMS
6.4 ELECTROSURGAL DEVICES
6.4.1 ELECTROCAUTERY DEVICES
6.4.1.1 High demand for precise cutting and coagulation to boost electrocautery device use in minimally invasive procedures
6.4.2 ELECTROSURGICAL GENERATORS & ACCESSORIES
6.4.2.1 Growing use of disposables and reusable instruments to propel segment growth
6.5 ENDOSCOPY DEVICES
6.5.1 RIGID ENDOSCOPES
6.5.1.1 Rising joint and urologic disorders to drive demand in high-volume minimally invasive surgeries
6.5.2 FLEXIBLE ENDOSCOPES
6.5.2.1 Increased preventive screening and early cancer detection to elevate flexible endoscope adoption
6.6 MEDICAL ROBOTICS
6.6.1 ROBOTIC SYSTEMS
6.6.1.1 Superior precision, enhanced control, and ability to perform complex procedures with greater dexterity to drive market
6.6.2 ROBOTIC INSTRUMENTS
6.6.2.1 Growing volume of robotic surgical procedures to augment market growth
6.6.3 ROBOTIC SOFTWARE & SERVICES
6.6.3.1 Rising robotic installations to increase demand for bundled training, maintenance, and technical support services

7 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 GASTROINTESTINAL & ABDOMINAL SURGERY
7.2.1 RISING GLOBAL BURDEN OF GASTROINTESTINAL CANCERS AND DIGESTIVE DISORDERS TO DRIVE MARKET
7.3 CARDIOTHORACIC SURGERY
7.3.1 INCREASING CARDIOVASCULAR AND THORACIC CONDITIONS TO INCREASE PRECISION-BASED MINIMALLY INVASIVE PROCEDURES
7.4 ORTHOPEDIC SURGERY
7.4.1 RISING BURDEN OF MUSCULOSKELETAL DISORDERS AND GROWING GERIATRIC POPULATION TO AID MARKET GROWTH
7.5 VASCULAR SURGERY
7.5.1 MINIMALLY INVASIVE VASCULAR SURGERY PRODUCTS TO REPLACE CONVENTIONAL SUTURE-BASED METHODS
7.6 GYNECOLOGICAL SURGERY
7.6.1 HIGH INCIDENCE OF GYNECOLOGICAL DISORDERS TO FUEL SEGMENT GROWTH
7.7 ONCOLOGICAL SURGERY
7.7.1 HIGH CANCER INCIDENCE AND ADOPTION OF ADVANCED PRECISION SURGICAL TECHNOLOGIES TO BOOST MARKET GROWTH
7.8 NEUROLOGICAL SURGERY
7.8.1 INCREASING GERIATRIC POPULATION AND RISING OCCURRENCE OF NEURODEGENERATIVE DISORDERS TO PROPEL MARKET GROWTH
7.9 UROLOGICAL SURGERY
7.9.1 INCREASING PREVALENCE OF UROLOGICAL CANCERS TO AUGMENT MARKET GROWTH
7.10 ENT & RESPIRATORY SURGERY
7.10.1 GROWING GLOBAL BURDEN OF COPD AND HEAD & NECK CANCERS TO DRIVE MARKET
7.11 COSMETIC SURGERY
7.11.1 HIGH DEMAND FOR AESTHETIC ENHANCEMENT WITH MINIMAL DOWNTIME TO PROPEL MARKET GROWTH
7.12 DENTAL SURGERY
7.12.1 RISING PATIENT DEMAND FOR LESS PAINFUL AND TISSUE-PRESERVING TREATMENTS TO FAVOR MARKET GROWTH
7.13 OTHER SURGERIES

8 MINIMALLY INVASIVE SURGERY MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS
8.2.1 RISING CHRONIC DISEASE BURDEN TO DRIVE PATIENT PREFERENCE FOR ADVANCED MINIMALLY INVASIVE SURGERIES IN HOSPITALS
8.3 AMBULATORY SURGERY CENTERS
8.3.1 GROWING PATIENT PREFERENCE FOR QUICKER DISCHARGE AND LOWER COSTS TO BOOST MARKET GROWTH
8.4 CLINICS
8.4.1 PREFERENCE FOR OUTPATIENT AND COST-EFFECTIVE MINIMALLY INVASIVE SURGICAL PROCEDURES TO AID MARKET GROWTH
8.5 EMERGENCY & TRAUMA CENTERS
8.5.1 INCREASING DEMAND FOR SAME-DAY SURGERIES TO AUGMENT MARKET GROWTH
8.6 OTHER END USERS

9 MINIMALLY INVASIVE SURGERY MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2 US
9.2.2.1 US to dominate North American minimally invasive surgery market during forecast period
9.2.3 CANADA
9.2.3.1 High geriatric population with chronic diseases to propel market growth
9.3 EUROPE
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2 GERMANY
9.3.2.1 Increased cancer incidence and strong healthcare infrastructure to fuel market growth
9.3.3 UK
9.3.3.1 Increasing geriatric population and rising need for oncological surgeries to stimulate market growth
9.3.4 FRANCE
9.3.4.1 High burden of non-communicable diseases to accelerate demand for minimally invasive procedures
9.3.5 ITALY
9.3.5.1 Increasing geriatric population to support adoption of minimally invasive procedures in degenerative conditions
9.3.6 SPAIN
9.3.6.1 Robust public healthcare and focus on reduced post-operative complications to augment market growth
9.3.7 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2 CHINA
9.4.2.1 Growing need for less invasive and high-precision surgical interventions to drive market
9.4.3 INDIA
9.4.3.1 Need for cost-effective and efficient surgical options in resource-constrained healthcare system to drive adoption
9.4.4 JAPAN
9.4.4.1 Advanced medical technology adoption and strong focus on patient-centric care to accelerate market growth
9.4.5 SOUTH KOREA
9.4.5.1 High demand for plastic surgeries and adoption of advanced robotics to aid market growth
9.4.6 AUSTRALIA
9.4.6.1 Increasing chronic disease burden and booming cosmetic surgery rates to fuel market expansion
9.4.7 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2 BRAZIL
9.5.2.1 Substantial public health investment and advanced dual public-private healthcare system to favor market growth
9.5.3 MEXICO
9.5.3.1 Rising obesity across age groups to fuel demand for minimally invasive surgical procedures in Mexican healthcare system
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
9.6.2 GCC COUNTRIES
9.6.2.1 Increased government healthcare investments and adoption of advanced medical technologies to spur market growth
9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MINIMALLY INVASIVE SURGERY MARKET
10.3 REVENUE ANALYSIS, 2020-2024
10.4 MARKET SHARE ANALYSIS, 2024
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
10.5.5.1 Company footprint
10.5.5.2 Region footprint
10.5.5.3 Product footprint
10.5.5.4 Application footprint
10.5.5.5 End-user footprint
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
10.6.5.1 Detailed list of key startups/SMEs
10.6.5.2 Competitive benchmarking of key startups/SMEs
10.7 COMPANY VALUATION & FINANCIAL METRICS
10.7.1 FINANCIAL METRICS
10.7.2 COMPANY VALUATION
10.8 BRAND/PRODUCT COMPARISON
10.9 COMPETITIVE SCENARIO
10.9.1 PRODUCT LAUNCHES AND APPROVALS
10.9.2 DEALS

11 COMPANY PROFILES
11.1 KEY PLAYERS
11.1.1 MEDTRONIC
11.1.1.1 Business overview
11.1.1.2 Products offered
11.1.1.3 Recent developments
11.1.1.3.1 Product approvals
11.1.1.3.2 Expansions
11.1.1.4 MnM view
11.1.1.4.1 Right to win
11.1.1.4.2 Strategic choices
11.1.1.4.3 Weaknesses & competitive threats
11.1.2 JOHNSON & JOHNSON
11.1.2.1 Business overview
11.1.2.2 Products offered
11.1.2.3 Recent developments
11.1.2.3.1 Product approvals
11.1.2.3.2 Deals
11.1.2.4 MnM view
11.1.2.4.1 Right to win
11.1.2.4.2 Strategic choices
11.1.2.4.3 Weaknesses & competitive threats
11.1.3 STRYKER
11.1.3.1 Business overview
11.1.3.2 Products offered
11.1.3.3 Recent developments
11.1.3.3.1 Product launches and approvals
11.1.3.3.2 Deals
11.1.3.4 MnM view
11.1.3.4.1 Right to win
11.1.3.4.2 Strategic choices
11.1.3.4.3 Weaknesses & competitive threats
11.1.4 BOSTON SCIENTIFIC CORPORATION
11.1.4.1 Business overview
11.1.4.2 Products offered
11.1.4.3 Recent developments
11.1.4.3.1 Deals
11.1.4.4 MnM view
11.1.4.4.1 Right to win
11.1.4.4.2 Strategic choices
11.1.4.4.3 Weaknesses & competitive threats
11.1.5 ABBOTT
11.1.5.1 Business overview
11.1.5.2 Products offered
11.1.5.3 Recent developments
11.1.5.3.1 Deals
11.1.5.4 MnM view
11.1.5.4.1 Right to win
11.1.5.4.2 Strategic choices
11.1.5.4.3 Weaknesses & competitive threats
11.1.6 ZIMMER BIOMET
11.1.6.1 Business overview
11.1.6.2 Products offered
11.1.6.3 Recent developments
11.1.6.3.1 Product approvals
11.1.6.3.2 Deals
11.1.7 B. BRAUN SE
11.1.7.1 Business overview
11.1.7.2 Products offered
11.1.8 GLOBUS MEDICAL
11.1.8.1 Business overview
11.1.8.2 Products offered
11.1.8.3 Recent developments
11.1.8.3.1 Deals
11.1.9 INTEGRA LIFESCIENCES CORPORATION
11.1.9.1 Business overview
11.1.9.2 Products offered
11.1.10 SIEMENS HEALTHINEERS AG
11.1.10.1 Business overview
11.1.10.2 Products offered
11.1.10.3 Recent developments
11.1.10.3.1 Product launches
11.1.10.3.2 Expansions
11.1.11 FUJIFILM CORPORATION
11.1.11.1 Business overview
11.1.11.2 Products offered
11.1.11.3 Recent developments
11.1.11.3.1 Product launches and approvals
11.1.11.3.2 Deals
11.1.12 KONINKLIJKE PHILIPS N.V.
11.1.12.1 Business overview
11.1.12.2 Products offered
11.1.12.3 Recent developments
11.1.12.3.1 Product launches and approvals
11.1.12.3.2 Deals
11.1.13 INTUITIVE SURGICAL OPERATIONS, INC.
11.1.13.1 Business overview
11.1.13.2 Products offered
11.1.13.3 Recent developments
11.1.13.3.1 Product approvals
11.1.14 KARL STORZ SE & CO. KG
11.1.14.1 Business overview
11.1.14.2 Products offered
11.1.14.3 Recent developments
11.1.14.3.1 Deals
11.1.14.3.2 Expansions
11.1.15 GE HEALTHCARE
11.1.15.1 Business overview
11.1.15.2 Products offered
11.1.15.3 Recent developments
11.1.15.3.1 Product launches
11.1.15.3.2 Deals
11.2 OTHER PLAYERS
11.2.1 NIPRO
11.2.2 SMITH+NEPHEW
11.2.3 GETINGE
11.2.4 CONMED CORPORATION
11.2.5 TELEFLEX INCORPORATED
11.2.6 OLYMPUS CORPORATION
11.2.7 COOPERSURGICAL, INC.
11.2.8 APPLIED MEDICAL RESOURCES CORPORATION
11.2.9 OTU MEDICAL
11.2.10 ATMOS MEDIZINTECHNIK GMBH & CO. KG

12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS